Skip to main content
. 2022 Apr 26;23(9):4782. doi: 10.3390/ijms23094782

Figure 1.

Figure 1

Neuroblastoma patients bearing high CTSD transcript level show a better prognosis. (A) Box-plot showing the distribution of CTSD expression. (B) Kaplan–Meier plot representing the overall survival of neuroblastoma patients according to CTSD expression levels (high and low). (C) Low expression of CTSD correlates with INSS Stage 4 in neuroblastoma patients.